Selux Diagnostics: John Wilson

Selux Diagnostics has named John Wilson as chief commercial officer. Wilson Wilson will lead the company's revenue growth for its rapid antimicrobial susceptibility testing technology as Selux prepares to commercialize its Next-Generation 'Phenotyping' (NGP) platform. Wilson most recently served as vice president of sales at GenMark Diagnostics. Prior to that, he held the mid-Atlantic sales time of Roche Tissue Diagnostics after Ventana Medical Systems was acquired by Roche.